Primary Record
Tolvaptan
- In stock
- 7,856 g
- Purity
- 99.7 %
- CAS
- 150683-30-0
Compound Identifiers & Properties
- CAS
- 150683-30-0
- PubChem CID
- 216237
- SMILES
- CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
- Canonical SMILES
- Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1
Names & Synonyms
- Tolvaptan
- Samsca
- 150683-30-0
- jinarc
- (R)-(+)-Tolvaptan
- tolvaptanum
- OPC-41061
- Tolvaptan?
- Tolvaptan RS
- Tolvaptan-d7
- JYNARQUE
- Tolvaptan [INN]
- Samsca (TN)
- Tolvaptan (Standard)
- (S)-(-)-Tolvaptan
- OPC 41061
- RefChem:56517
- TOLVAPTAN [JAN]
- benzazepine derivative, 32
- TOLVAPTAN [MI]
- Tolvaptan [USAN:INN]
- TOLVAPTAN [USAN]
- Samsca;OPC-41061
- TOLVAPTAN [VANDF]
- C26H25ClN2O3
- DTXSID3048780
- Tolvaptan (OPC-41061)
- Tolvaptan [USAN:INN:BAN]
- CHEBI:32246
- D03KZM
- TOLVAPTAN [MART.]
- TOLVAPTAN [WHO-DD]
- CHEMBL344159
- UNII-21G72T1950
- Epitope ID:1635951
- MFCD09838782
- DTXCID9028706
- TOLVAPTAN [EMA EPAR]
- HSDB 8196
- SCHEMBL242421
- Tolvaptan - Bio-X trade mark
- 2-Demethyl 3-Methyl Tolvaptan
- AC1L50C9
- GTPL2226
- orb1305683
- TOLVAPTAN [ORANGE BOOK]
- SCHEMBL29389767
- SCHEMBL29720852
- SCHEMBL29776655
- BDBM35723
- CTK8B8272
- C03XA01
- OPC-41061(TOLVAPTAN)
- CHEBI:231425
- GYHCTFXIZSNGJT-UHFFFAOYSA-N
- HMS3604L08
- HMS3656K20
- HMS3744A09
- HMS5081B09
- C26-H25-Cl-N2-O3
- MSK11103
- N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide
- OPC41061
- N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
- Tox21_113256
- ANW-59865
- CID216237
- CT0200
- EBC-07798
- HY-17000R
- NCGC00183001-01
- PDSP1_001738
- PDSP2_001721
- s2593
- 21G72T1950
- AKOS015994735
- Tolvaptan, >=98% (HPLC), powder
- ACN-040195
- AN-5238
- CCG-269223
- CS-0572
- CS-O-31027
- FT34175
- KS-1315
- 4CA-1265
- AC-22748
- AK-33401
- BC650606
- BT164486
- HY-17000
- AB0009995
- AB2000685
- TC-148610
- (R)-(+)-OPC-41061
- AM20090726
- CAS-150683-30-0
- ST24031322
- SW219182-1
- J1.047.795F
- EN300-123019
- AB01565822_02
- 683T300
- A809063
- L001628
- Q426132
- SR-01000942265
- 331947-66-1
- SR-01000942265-1
- BRD-A82035391-001-02-7
- 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
- N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide
- Z1546610480
- N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
- 331947-44-5
- Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-
- H-D-PHE-PRO-ARG-5-AMIDO-ISOPHTHALICACID-DIMETHYLESTERACETATESALT
- N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]-azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide
- N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide
- N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide
- (+-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl) carbonyl)-o-tolu-m-toluidide
- (+-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
- (+/-)-4'-((7-CHLORO-2,3,4,5-TETRAHYDRO-5-HYDROXY-1H-1-BENZAZEPIN-1-YL) CARBONYL)-O-TOLU-M-TOLUIDIDE
- (-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
- 1-[4-(2-methylbenzoylamino)-2-methylbenzoyl]-7-chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-ol
- 4 -[(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-yl)carbonyl]-2,3 -dimethylbenzanilide
- 4 -[(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benz[b]azepin-1-yl)carbonyl]-2,3 -dimethylbenzanilide
- 5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1h-benzazepine
- 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methyl benzoyl amino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine
- 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine
- 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benz-azepine
- 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine
- Benzamide, N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-
- Benzamide,N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-
- N-(4-(7-chloro-5-hydroxy2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide
- N-[3-Methyl-4-(5-hydroxy-7-chloro-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-ylcarbonyl)phenyl]-2-methylbenzamide
- N-[3-Methyl-4-[[(5-hydroxy-7-chloro-2,3,4,5-tetrahydro-1H-1-benzazepine)-1-yl]carbonyl]phenyl]-2-methylbenzamide
- N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2,3,4,5-tetradeuterio-6-(trideuteriomethyl)benzamide
- N-[4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-benzo[b]azepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide
- N-[4-(7-chloro-5-hydroxy2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
- N-[4-[(2,3,4,5-Tetrahydro-5-hydroxy-7-chloro-1H-1-benzoazepine-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide
- N-[4-[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methylphenyl]-2-methylbenzamide
- N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-benzamide; 1H-1-Benzazepine, benzamide deriv.; 1-[4-(2-Methylbenzoylamino)-2-methylbenzoyl]-7-chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-ol; OPC 41061; Samsca; Tolvaptan
- N-{4-[(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl}-2-methylbenzamide